Insulin Glargine



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 33.5%
Diabetes Mellitus 24.8%
Hypertension 9.3%
Product Used For Unknown Indication 7.8%
Type 1 Diabetes Mellitus 4.5%
Prophylaxis 3.4%
Diabetes Mellitus Insulin-dependent 2.6%
Coronary Artery Disease 2.3%
Device Therapy 2.2%
Suicide Attempt 1.3%
Hypothyroidism 1.2%
Drug Use For Unknown Indication 1.1%
Atrial Fibrillation 1.0%
Depression 1.0%
Dyslipidaemia 0.8%
Cardiovascular Event Prophylaxis 0.7%
Myocardial Infarction 0.7%
Myocardial Ischaemia 0.7%
Diabetic Relative 0.6%
Insulin-requiring Type 2 Diabetes Mellitus 0.6%
Death 17.8%
Hypoglycaemia 13.3%
Myocardial Infarction 10.4%
Hyperglycaemia 5.8%
Acute Myocardial Infarction 5.4%
Renal Failure 4.1%
Suicide Attempt 4.1%
Dyspnoea 3.7%
Hospitalisation 3.3%
Pneumonia 3.3%
Renal Failure Acute 3.3%
Weight Increased 3.3%
Cerebrovascular Accident 2.9%
Hepatic Neoplasm Malignant 2.9%
Pancreatic Carcinoma 2.9%
Road Traffic Accident 2.9%
Vomiting 2.9%
Cerebral Thrombosis 2.5%
Loss Of Consciousness 2.5%
Mental Status Changes 2.5%
Secondary
Type 2 Diabetes Mellitus 64.0%
Product Used For Unknown Indication 18.3%
Diabetes Mellitus 3.5%
Drug Use For Unknown Indication 2.9%
Type 1 Diabetes Mellitus 2.8%
Device Therapy 1.8%
Hypertension 1.6%
Suicide Attempt 1.3%
Overdose 0.9%
Prophylaxis 0.6%
Depression 0.4%
Coronary Artery Disease 0.4%
Angina Pectoris 0.2%
Hypothyroidism 0.2%
Neuropathy Peripheral 0.2%
Constipation 0.2%
Hypercholesterolaemia 0.2%
Insomnia 0.2%
Insulin-requiring Type 2 Diabetes Mellitus 0.2%
Rheumatoid Arthritis 0.2%
Renal Failure Acute 15.5%
Suicide Attempt 11.5%
Hypoglycaemia 11.1%
Hypotension 7.1%
Blood Glucose Increased 5.8%
Malaise 5.8%
Somnolence 4.9%
Diabetic Ketoacidosis 4.4%
Coronary Artery Stenosis 3.5%
Hepatic Function Abnormal 3.5%
Vomiting 3.1%
Weight Increased 3.1%
Acute Myocardial Infarction 2.7%
Diabetic Complication 2.7%
Disseminated Intravascular Coagulation 2.7%
Hyperglycaemia 2.7%
Pancreatic Carcinoma 2.7%
Tremor 2.7%
Vitreous Haemorrhage 2.7%
Nausea 2.2%
Concomitant
Drug Use For Unknown Indication 26.4%
Product Used For Unknown Indication 21.7%
Diabetes Mellitus 13.2%
Type 2 Diabetes Mellitus 9.4%
Hypertension 7.5%
Type 1 Diabetes Mellitus 2.8%
Pain 2.5%
Rheumatoid Arthritis 2.1%
Hiv Infection 2.0%
Prophylaxis 1.9%
Pneumocystis Jiroveci Pneumonia 1.8%
Depression 1.3%
Insomnia 1.0%
Constipation 1.0%
Hypothyroidism 0.9%
Hypercholesterolaemia 0.9%
Nausea 0.9%
Pulmonary Tuberculosis 0.9%
Gastrooesophageal Reflux Disease 0.9%
Blood Cholesterol Increased 0.8%
Vomiting 16.7%
Rhabdomyolysis 9.3%
Weight Decreased 8.1%
Drug Ineffective 5.7%
Hypoglycaemia 5.4%
Renal Failure Acute 5.0%
Myocardial Infarction 4.8%
Renal Failure 4.5%
Respiratory Failure 4.5%
Nausea 4.3%
Thrombocytopenia 4.1%
Weight Increased 4.1%
Tremor 3.6%
Urinary Tract Infection 3.6%
Blood Glucose Increased 2.9%
Pyrexia 2.9%
Colon Cancer 2.7%
Diabetes Mellitus Inadequate Control 2.7%
Anuria 2.5%
Death 2.5%
Interacting
Drug Use For Unknown Indication 25.5%
Diabetes Mellitus 16.3%
Depression 15.2%
Tachyarrhythmia 7.6%
Type 2 Diabetes Mellitus 5.4%
Blood Cholesterol Increased 3.8%
Dyslipidaemia 3.8%
High Density Lipoprotein Decreased 3.8%
Chronic Obstructive Pulmonary Disease 3.3%
Hypertension 3.3%
Diabetes Mellitus Insulin-dependent 2.2%
Infection 2.2%
Dementia 1.1%
Heart Valve Incompetence 1.1%
Hypothyroidism 1.1%
Osteoporosis Prophylaxis 1.1%
Product Used For Unknown Indication 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Rheumatoid Arthritis 1.1%
Myocardial Infarction 41.2%
Hypoglycaemia 35.3%
Mobility Decreased 11.8%
Renal Impairment 5.9%
Skin Ulcer 5.9%